Vor Biopharma Income Statement (2020-2026) | VOR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Shares Outstanding (Entity) (Quarter)																				59.16M
Operating items
Research & Development (Quarter)	12.93M	12.69M	15.28M	15.33M	16.88M	17.06M	21.91M	23.90M	27.61M	20.90M	24.32M	21.82M	21.82M	25.35M	26.70M	261.50M	14.14M	19.19M	17.59M	25.92M
Selling, General & Administrative (Quarter)	5.68M	5.61M	7.52M	6.46M	7.23M	7.66M	8.51M	8.28M	7.71M	7.23M	8.00M	7.21M	6.70M	5.96M	6.59M	12.79M	13.96M	16.77M	17.57M	21.93M
Operating Expenses (Quarter)																				47.85M
Other Operating Expenses (Quarter)																		98.93M
Operating Income (Quarter)																				-47.85M
EBIT (Quarter)																				-47.85M
Non-operating items
Interest & Investment Income (Quarter)																				4.34M
Other Non Operating Income (Quarter)																	4.15M	0.00M
Non Operating Income (Quarter)																				-14.96M
Net income details
EBT (Quarter)																				-44.43M
Profit After Tax (Quarter)																				-63.03M
Income from Non-Controlling Interests (Quarter)																				-0.22M
Income from Continuing Operations (Quarter)																				-44.43M
Consolidated Net Income (Quarter)																				-44.43M
Income towards Parent Company (Quarter)																				-44.43M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)																				-44.43M
Additional items
EPS (Basic) (Quarter)																				-0.82
EPS (Diluted) (Quarter)																				-0.82
Shares Outstanding (Quarter)																				54.30M
Shares Outstanding (Diluted) (Quarter)																				54.30M
EBITDA (Quarter)																				-47.85M
Interest Expenses (Quarter)																				0.92M